Cargando…

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice

BACKGROUND: SARS-CoV-2 has caused a global pandemic, infecting millions of people. A safe, effective vaccine is urgently needed and remains a global health priority. Subunit vaccines are used successfully against other viruses when administered in the presence of an effective adjuvant. METHODS: We e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wørzner, Katharina, Sheward, Daniel J., Schmidt, Signe Tandrup, Hanke, Leo, Zimmermann, Julie, McInerney, Gerald, Hedestam, Gunilla B. Karlsson, Murrell, Ben, Christensen, Dennis, Pedersen, Gabriel Kristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808923/ https://www.ncbi.nlm.nih.gov/pubmed/33422991 http://dx.doi.org/10.1016/j.ebiom.2020.103197

Ejemplares similares

SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses
por: Mandolesi, Marco, et al.
Publicado: (2021)

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
por: Hanke, Leo, et al.
Publicado: (2020)

Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction
por: Wørzner, Katharina, et al.
Publicado: (2021)

Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs
por: Moliner-Morro, Ainhoa, et al.
Publicado: (2020)

Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies
por: Pushparaj, Pradeepa, et al.
Publicado: (2023)

SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses
por: Christensen, Dennis, et al.
Publicado: (2023)

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
por: Sheward, Daniel J., et al.
Publicado: (2021)

A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo
por: Hanke, Leo, et al.
Publicado: (2022)

DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice
por: Szurgot, Inga, et al.
Publicado: (2021)

Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates
por: Castro Dopico, Xaquin, et al.
Publicado: (2022)

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses
por: Pushparaj, Pradeepa, et al.
Publicado: (2023)

Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses
por: Pedersen, Gabriel Kristian, et al.
Publicado: (2020)

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies
por: Hanke, Leo, et al.
Publicado: (2022)

Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactant
por: Gupta, Govind, et al.
Publicado: (2022)

A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease
por: Zimmermann, Julie, et al.
Publicado: (2022)

Sequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infection
por: Panas, Marc D., et al.
Publicado: (2012)

Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b
por: Schmidt, Signe Tandrup, et al.
Publicado: (2020)

Influenza A virus-mediated priming enhances cytokine secretion by human dendritic cells infected with Streptococcus pneumoniae
por: Kuri, Thomas, et al.
Publicado: (2013)

HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies
por: Sheward, Daniel J., et al.
Publicado: (2022)

Antigen receptor stimulation induces purifying selection against pathogenic mitochondrial tRNA mutations
por: Zhang, Jingdian, et al.
Publicado: (2023)

Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
por: Custódio, Tânia F., et al.
Publicado: (2020)

Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden
por: Castro Dopico, X., et al.
Publicado: (2021)

Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
por: Sundling, Christopher, et al.
Publicado: (2010)

Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
por: Sundling, Christopher, et al.
Publicado: (2010)

Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C)
por: Schmidt, Signe Tandrup, et al.
Publicado: (2018)

Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
por: Tandrup Schmidt, Signe, et al.
Publicado: (2016)

Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy
por: Christensen, Dennis, et al.
Publicado: (2022)

Evasion of neutralising antibodies by omicron sublineage BA.2.75
por: Sheward, Daniel J, et al.
Publicado: (2022)

HIV-1 Env-Specific Memory and Germinal Center B Cells in C57BL/6 Mice
por: Soldemo, Martina, et al.
Publicado: (2014)

Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
por: Hellgren, Fredrika, et al.
Publicado: (2023)

A Multiparametric and High-Throughput Platform for Host–Virus Binding Screens
por: Schlegel, Jan, et al.
Publicado: (2023)

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
por: Sheward, Daniel J, et al.
Publicado: (2022)

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
por: Sheward, Daniel J, et al.
Publicado: (2022)

Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine
por: Li, Chia-Jung, et al.
Publicado: (2023)

Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
por: Hellgren, Fredrika, et al.
Publicado: (2023)

Flow Cytometry-Based Protocols for the Analysis of Human Plasma Cell Differentiation
por: Khoenkhoen, Sharesta, et al.
Publicado: (2020)

Env-Specific Antibodies in Chronic Infection versus in Vaccination
por: Soldemo, Martina, et al.
Publicado: (2017)

Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
por: Bowen, John E., et al.
Publicado: (2022)

Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation
por: Martinez, Paola, et al.
Publicado: (2015)

The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile
por: Schmidt, Signe Tandrup, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gh59joe0hjd36pdvp10c52ehj2